Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. - Wikidata - awgldk - TriplyDB

Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.

Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.

http://www.wikidata.org/entity/Q35787792

about

Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression Vaccines for pancreatic cancer Interleukin 12: still a promising candidate for tumor immunotherapy?Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth.Selected cytokines in patients with pancreatic cancer: a preliminary report.An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer Role of transforming growth factor beta in cancer.Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival.Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.A critical review of T cell targeting immunotherapy in pancreatic cancer: only a hypothesis or a real hope for the patients?Cytokines and antitumor immunity.Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance Immunotherapy for pancreatic cancer - science driving clinical progress.The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma Diagnostic Role of Platelet Lymphocyte Ratio(PLR) in Pancreatic Head Masses.The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis.Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.Disrupting cytokine signaling in pancreatic cancer: a phase I/II study of etanercept in combination with gemcitabine in patients with advanced disease Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer.Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo.Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors.Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays Role of immune cells in pancreatic cancer from bench to clinical application: An updated review The immune network in pancreatic cancer development and progression.Towards a commercial process for the manufacture of genetically modified T cells for therapy.Latent effects of fibronectin, alpha5beta1 integrin, alphaVbeta5 integrin and the cytoskeleton regulate pancreatic carcinoma cell IL-8 secretion.T-cell programming in pancreatic adenocarcinoma: a review.B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.Targeting TGF-β Signaling for Therapeutic Gain.

P2860

Q24793668-D1999155-D64F-4DA3-B363-0119A6337C46 Q26765238-D7FC9651-4919-43C4-9DE9-6551B9551238 Q26825850-F1113DFD-BA5B-4BD5-9163-2DD98ADAAFD3 Q26861559-6F76A034-899C-4D88-8256-6F2189D67E3F Q28079823-576BAC40-3C9F-4CED-8646-C027C0AF561B Q28083684-F3580045-252A-402C-919B-7CC94E69DE1D Q30426606-1421DB91-BFB1-4C1F-B05B-695AE8C018FD Q33595431-99072994-F874-4CDF-96A2-63B052CE51F0 Q33645140-8429B3A0-1434-406F-85C3-69B98B9B3982 Q33812340-0BA865D5-026A-4369-9DEC-E4C9FD149906 Q34136011-355949DD-BB14-401B-9F15-96E65258652A Q34442209-F4423FF3-D0BD-4D5F-8515-AFF5A15865B3 Q34646946-3C248511-73A9-40AE-88DE-48258F88D658 Q34974725-FA9A8A7B-8F14-4204-A84B-FF9AE58E9F77 Q35142319-2A5A003E-56A0-4330-B769-3852E2225CF7 Q35202177-822AA930-52F5-483C-9D98-1A9AFA820E22 Q35222367-64273FEA-840B-4B55-A65A-D4D24790ADC6 Q35870682-2F0A17C0-1621-404E-BEE0-42C01670B8D7 Q35886496-172DA70F-2FA9-4207-A45F-55124EFAAE85 Q36067334-40650053-9E35-4FD3-805D-74D4B70BFDCE Q36133140-822FDC4A-6F96-4D12-9864-F1AF0B244B5D Q36202213-535533E0-3EE2-4657-8DE7-DB72208C0E6E Q36371068-183142D2-6AA2-4383-B379-C42C9805A7F6 Q36648293-1C18DFE8-4D40-4DEE-B033-C106074BE716 Q36677504-ED379F0C-8A3D-4AE5-8362-27691D007648 Q36713246-3E953E4A-6616-42A0-BB39-9AD25C1B286A Q36810574-9D7AD756-7ABE-48FF-A9F5-42020A334E1C Q36876297-34A5A846-61ED-43A0-A115-56799DD73555 Q36902015-A6F8C6BE-1FA5-41DB-93EE-93AA71FCD643 Q37001451-B5BF0EAD-2124-40D0-979D-AFB6D78A1E94 Q37346107-2C6E3F58-69AE-4247-8822-ABA4363B1BB3 Q37389994-AB1B6D6C-ADD6-4243-BD06-2BDDA61AD40A Q37516483-97CCE1D4-E46A-433D-97FF-5080FB6B3F12 Q37606102-C8ADABD0-4BDC-4BB7-A1CA-964EA0E50F8A Q38121412-E43C7D49-0359-4AD5-8DF2-5A6D231748F1 Q38329158-BAF0B830-DF6D-47F7-85BB-E04F7EC1E0C0 Q38801587-DC8A8A08-DFF9-4E46-BA8D-202330D76168 Q39026966-628ADC84-8D17-483B-A463-216639FC108B Q39154102-5C8F27FA-5960-4967-B8A2-9041FD9A6F75 Q39155151-632F9BFB-1D25-4E7C-B507-6191F8DADBD8

P2860

Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.

http://www.wikidata.org/entity/Q35787792

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Tumor-associated transforming ...... pancreatic carcinoma patients.

@ast

Tumor-associated transforming ...... pancreatic carcinoma patients.

@en

type

label

Tumor-associated transforming ...... pancreatic carcinoma patients.

@ast

Tumor-associated transforming ...... pancreatic carcinoma patients.

@en

prefLabel

Tumor-associated transforming ...... pancreatic carcinoma patients.

@ast

Tumor-associated transforming ...... pancreatic carcinoma patients.

@en

P1433

Q35787792-746C045F-68F0-4428-A257-39C0384563B0

P1476

Q35787792-74EB0581-FD52-47D1-A231-F37C0A70A894

P2093

Q35787792-01A94B12-344E-4C31-BE79-F4F6DF873E15

Q35787792-3DB37A7E-6E1A-431B-898C-9136CE83BB36

Q35787792-4003892F-C073-4C0E-83E5-710F2697B7E0

Q35787792-6B89EDC5-2513-47C2-8861-79AE13307347

Q35787792-7AF978B6-74F4-4984-9A3D-E41380911663

Q35787792-7EE6FE03-7FA8-41D1-89AE-88752654CFCC

Q35787792-8C9B045B-6C6A-4ECD-A7B5-B77A2982A8D0

Q35787792-BB29A1AD-F595-4EED-B78D-426C947FA889

Q35787792-E34616A5-5A4F-4EC9-AA26-62B4B6279A25

P2860

Q35787792-028863FA-84CB-4EDD-A60B-5D3B88FF8C8D

Q35787792-0DFC6B3F-E424-4BBD-B483-F76723299999

Q35787792-1D870FE5-ED7D-4622-81F0-E622D10BFF61

Q35787792-2181D8DE-96BC-4030-B7C9-7B5A9EB95B3C

Q35787792-267849C8-5867-427A-BE20-94CDA1CB7345

Q35787792-267C8285-9EB5-4CF2-981D-DE9E85BE1ECA

Q35787792-2964C5CF-B6EA-436B-9ED8-C24F9C3D120A

Q35787792-2A8DB715-AC8A-40E4-AE7D-A1479FDA5CC5

Q35787792-2AD3F69F-C6C5-494E-A681-5E2232475F49

Q35787792-4004EC9F-5F08-4406-8BFB-8941CAB2A9D3

P304

Q35787792-21D0E31C-6ECD-4671-8224-A66DB881BBDF

P31

Q35787792-98B158F0-C098-41CD-A3EB-AA97F160B97B

P356

Q35787792-7AF66B32-4A90-4147-9D97-A470FBB68C2B

P407

Q35787792-07ECDCC4-8DDB-4E64-B67C-B0F36D91C0F4

P433

Q35787792-97DE886D-B4FC-4C44-BA8F-DCEC9BDE19B3

P478

Q35787792-B9C29E47-AC90-4363-BFC8-0460B1BE27DB

P577

Q35787792-D84DB780-EBB3-4617-A809-F62D98EC86F4

P5875

Q35787792-41FBA5D2-03CC-47B5-8D06-142A48D38AE9

P698

Q35787792-014F8582-36F0-40CD-9DE7-FC778AC18935

P932

Q35787792-025B492F-142D-48E0-B763-574528ED995D

P356

S0002-9440(10)65149-8

P1433

The American Journal of Pathology

P1476

Tumor-associated transforming ...... pancreatic carcinoma patients.

@en

P2093

A Carbone

http://www.w3.org/2001/XMLSchema#string

A Robecchi

http://www.w3.org/2001/XMLSchema#string

A Turletti

http://www.w3.org/2001/XMLSchema#string

D Tibaudi

http://www.w3.org/2001/XMLSchema#string

E Artusio

http://www.w3.org/2001/XMLSchema#string

G Bellone

http://www.w3.org/2001/XMLSchema#string

G Emanuelli

http://www.w3.org/2001/XMLSchema#string

K Mareschi

http://www.w3.org/2001/XMLSchema#string

U Rodeck

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

The transforming growth factor-beta family

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

Local expression of antiinflammatory cytokines in cancer

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

P304

537-547

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)65149-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

251446292

http://www.w3.org/2001/XMLSchema#string

P698

10433946

http://www.w3.org/2001/XMLSchema#string

P932

1866873

http://www.w3.org/2001/XMLSchema#string